Decentralized Clinical Trials Forum 2022

Jennifer C. Goldsack co-founded and serves as the CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Jennifer’s research focuses on applied approaches to the safe, effective, and equitable... Read More →

Katrine has been with Biogen since 2013 and is currently the Head of Payer & Health Ecosystem Value and Strategy in Biogen Digital Health (BDH). She is responsible for ensuring that the payer and health ecosystem perspectives and needs are integral parts of strategies and activities... Read More →

Curren Katz, PhD brings 15+ years of healthcare experience across payer, provider and pharmaceutical. As Sr. Director of Data Science at Janssen R&D, Curren leads Portfolio Strategy & Governance and Real-World Data for Neuroscience. Since joining Janssen in May of 2021, Curren has... Read More →

Jiat Ling (Jiat) Poon is a Director in Value, Evidence, and Outcomes at Eli Lilly and Company, responsible for the development of innovative patient-focused endpoints and measurement strategies to support drug development across Lilly’s portfolio. Jiat has over 8 years of experience... Read More →